Tom Gillingwater's group, working alongside Professor Kevin Talbot's group at the University of Oxford, have been awarded £493,272 from the My Name'5 Doddie Foundation to undertake cutting-edge research into new therapies for motor neurone disease. This funding represents a major new investment in motor neurone disease research at the University of Edinburgh, and strengthens existing multi-disciplinary, collaborative research between Edinburgh and Oxford that is seeking to find new treatments and therapies for these conditions. Related link More details can be found at My Name'5 Doddie Foundation Publication date 06 Mar, 2019
